DOP2003000564A - ACIDS 3- (IMIDAZOLIL) -2-ALCOXIPROPANOICOS - Google Patents

ACIDS 3- (IMIDAZOLIL) -2-ALCOXIPROPANOICOS

Info

Publication number
DOP2003000564A
DOP2003000564A DO2003000564A DO2003000564A DOP2003000564A DO P2003000564 A DOP2003000564 A DO P2003000564A DO 2003000564 A DO2003000564 A DO 2003000564A DO 2003000564 A DO2003000564 A DO 2003000564A DO P2003000564 A DOP2003000564 A DO P2003000564A
Authority
DO
Dominican Republic
Prior art keywords
alcoxipropanoicos
imidazolil
acids
alkyl
hydrogen
Prior art date
Application number
DO2003000564A
Other languages
Spanish (es)
Inventor
Robert John Maguire
Mark Edward Bunnage
Allerton Charlotte Moira Norfor
John Steele
David John Bull
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to DO2003000564A priority Critical patent/DOP2003000564A/en
Publication of DOP2003000564A publication Critical patent/DOP2003000564A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los compuestos de acuerdo con la formula (I) en la que n es 0-3, R1 es alquilo C1-6 opcionalmente sustituido, alquenilo C2-6 o alquinilo C2-6, heterociclo, heterociclo aromatico, arilo o hidrogeno y cada uno de R2, R3, R4, R5, R6, R', R8 y R9 se selecciona independientemente entre hidrogeno y alquilo C1-6 opcionalmente sustituido, o R5 y R8 son una cadena alquileno, son novedosos. Estos compuestos son utiles en el tratamiento de afecciones tromboticas y otras patologias asociadas con la deposicion de fibrina.The compounds according to formula (I) in which n is 0-3, R1 is optionally substituted C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl, heterocycle, aromatic heterocycle, aryl or hydrogen and each of R2, R3, R4, R5, R6, R ', R8 and R9 are independently selected from hydrogen and optionally substituted C1-6 alkyl, or R5 and R8 are an alkylene chain, they are novel. These compounds are useful in the treatment of thrombotic conditions and other pathologies associated with the deposition of fibrin.

DO2003000564A 2003-01-17 2003-01-17 ACIDS 3- (IMIDAZOLIL) -2-ALCOXIPROPANOICOS DOP2003000564A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2003000564A DOP2003000564A (en) 2003-01-17 2003-01-17 ACIDS 3- (IMIDAZOLIL) -2-ALCOXIPROPANOICOS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2003000564A DOP2003000564A (en) 2003-01-17 2003-01-17 ACIDS 3- (IMIDAZOLIL) -2-ALCOXIPROPANOICOS

Publications (1)

Publication Number Publication Date
DOP2003000564A true DOP2003000564A (en) 2003-07-31

Family

ID=44261133

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2003000564A DOP2003000564A (en) 2003-01-17 2003-01-17 ACIDS 3- (IMIDAZOLIL) -2-ALCOXIPROPANOICOS

Country Status (1)

Country Link
DO (1) DOP2003000564A (en)

Similar Documents

Publication Publication Date Title
UY27522A1 (en) PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
AR025225A1 (en) PHYSYLOXAZOLIDINONES HETEROCICLIC BICYCLIC REPLACED ANTIBACTERIAL AND PHARMACEUTICAL COMPOSITIONS
NO20005237L (en) Heterocyclic substituted amides used as calpain inhibitors
AR048376A1 (en) C- SUBSTITUTED FUSIONED GLYCYCLE GLYCYCLES
PE20040688A1 (en) KINASE INHIBITORS
PE20070218A1 (en) AMINO-HYDANTOIN CYCLOALKYL COMPOUNDS AND USE OF THESE FOR THE MODULATION OF ß-SECRETASE
PE20070078A1 (en) MACROCICLIC HETEROCYCLIC COMPOUNDS AS ASPARTILE PROTEASE INHIBITORS
CY1108409T1 (en) OXAZOLIDINONE-KINOLON HYBRID ANTIBODIES
PE20050226A1 (en) ARIL-HETEROAROMATIC PRODUCTS AND COMPOSITIONS CONTAINING THEM
ECSP045200A (en) ACIDS 3- (IMIDAZOLIL) -2-ALCOXIPROPANOICOS
AR042362A1 (en) DERIVATIVES OF 3H-QUINAZOLIN-4-ONA, PROCESS OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PE20060103A1 (en) NEW 5-ACYLINDOLINONES WITH CYCLOALKYL CONTENT AND ITS PREPARATION AS A MEDICINAL PRODUCT
PE20040528A1 (en) PEPTIDE-DEFORMYLASE INHIBITORS
PE20050231A1 (en) DERIVATIVES OF PIPERIDINIUM AND PYRROLIDINIUM AS ANTAGONISTS OF THE MUSCARINIC M3 RECEPTOR
MXPA04005940A (en) 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases.
AR040140A1 (en) CAMPTOTECHINE ESTERS DERIVATIVES IN POSITION 20
AR054414A1 (en) ESPIRO-HYDANTOINE COMPOUNDS REPLACED WITH PIRIDILE. PHARMACEUTICAL COMPOSITIONS.
PE20030611A1 (en) LINEAR BASIC COMPOUNDS THAT HAVE ANTAGONIST ACTIVITY OF NK-2 AND ITS FORMULATIONS
PE20050120A1 (en) KITCHENS WITH A MODIFIED LACTONE RING
DE60124717D1 (en) ARYL-SULFONAMIDES AS SEROTONINE ANTAGONISTS FOR THE TREATMENT OF GRAVITY
EA200500133A1 (en) PYRROLIDINE DERIVATIVES AS ANTAGONISTS OF OXYTOCIN
DOP2003000564A (en) ACIDS 3- (IMIDAZOLIL) -2-ALCOXIPROPANOICOS
PE20010165A1 (en) DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYL-AMINOMETILCROMANO AS ANTAGONISTS OF SUBSTANCE P
UY27616A1 (en) ACIDS 3 - (AMIDAZOLIL) - AMINOPROPANOICS
DOP2003000560A (en) ACIDS 3- (IMIDAZOLIL) -2-AMINOPROPANOICS